By Jheri Hardaway
Staff Writer
Sanford, NC - When global enterprises evaluate where to lay their most strategic foundations, the balance sheet tells only part of the story. The deeper calculation hinges on infrastructure, community engagement, and a skilled workforce that understands how to translate science into life-saving realities.
Italian diagnostic imaging titan Bracco has officially cast its vote of confidence in North Carolina, announcing an audacious $230 million capital investment in Sanford to establish its first-ever manufacturing facility for injectable contrast media on American soil. The transformative move will generate at least 200 high-wage advanced manufacturing jobs in Lee County, cementing the Piedmont region’s role as an indispensable artery in the global medical supply chain.
For Bracco, a Milan-based, family-owned healthcare enterprise with deep global roots and specialized production footprints across Europe, Asia, and Canada, anchoring stateside operations is a deliberate move to insulate American clinical providers from supply disruptions while positioning production closer to its largest consumer base. Injectable contrast media serves as the vital visual engine behind modern diagnostic radiology, allowing physicians to detect cardiovascular anomalies, cancerous lesions, and neurological trauma through CT scans, MRIs, and X-rays.
“Producing injectable contrast media here in Sanford brings our supply closer to American hospitals and patients and makes it even more resilient,” noted Fulvio Renoldi Bracco, Vice Chairman and CEO of Bracco Imaging. “We chose North Carolina for its talent and life sciences ecosystem. As a family-owned company, we invest for the long term, and we look forward to growing with the Sanford community for decades to come.”
The 200 new roles planned for the Sanford campus will span the full operational spectrum: specialized biomanufacturing technicians, mechanical and chemical engineers, technical operators, regulatory and quality-assurance specialists, warehouse distribution coordinators, and executive administrative teams. Crucially, the economic impact reaches directly into the pocketbooks of local working families. With an expected average annual salary hovering near $103,000, these positions substantially exceed regional wage benchmarks, creating true upward mobility and generational wealth through local small businesses, schools, and civic institutions.
For Sanford and neighboring rural-adjacent communities across Lee and Harnett counties, the announcement represents intentional progression. Rather than watching high-paying technical careers remain exclusively concentrated inside the immediate Research Triangle perimeter, regional corridors of opportunity are demonstrating that historic manufacturing towns possess the land, logistics, and grit to support cutting-edge biotechnology.
Bracco’s entry into Sanford is no outlier; it is the natural consequence of North Carolina’s intentional, decades-long cultivation of its life sciences corridor. The Tar Heel State now boasts a dense network of more than 860 life sciences enterprises employing upwards of 76,000 people. By marrying top-tier Tier 1 research institutions and an agile community college training apparatus with deep East Coast freight networks, the state has an unmatched competitive edge.
The Sanford milestone joins an accelerating wave of capital expansion across our municipal landscape. In Henderson County, global manufacturing solutions leader Jabil invested more than $102 million in 2026 to scale its local footprint, marking the largest single-year economic development investment in the county's history and bringing 148 high-skill jobs with average wages topping $62,000.
In Wilson, consumer health giant Reckitt laid the groundwork in 2024 for a state-of-the-art regional manufacturing hub dedicated to over-the-counter mainstays like Mucinex. Set to open its doors in the first half of 2027, Reckitt has since doubled its initial $200 million capital commitment, reinforcing eastern North Carolina’s prowess in pharmaceutical production.
When international conglomerates commit hundreds of millions of dollars into North Carolina dirt, they are investing in the caliber and resilience of our people. Angela Naef, Ph.D., chief R&D officer at Reckitt, told Fierce Pharma, “This investment fundamentally changes how we innovate. By bringing science, insight and execution closer together, we can move faster from discovery to delivery, developing high-quality, science-led solutions that meet evolving consumer needs and scale globally.”
Bracco’s long-term wager on Sanford reflects a growing national recognition: true supply chain security cannot be managed from across an ocean. It must be built, monitored, and sustained right here at home.
As shovels turn and infrastructure takes shape in Lee County, North Carolina continues to prove that its industrial evolution is not a relic of the past, but a living, high-tech engine driving the state's economic sovereignty forward.
